The human world is currently influenced largely by the outbreak of pandemic COVID‐19. At
this moment, most researchers focus on developing treatment strategies and measures to …

Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

The ongoing SARS‐CoV‐2 pandemic stresses the need for effective antiviral drugs that can
quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By …

The current coronavirus disease 2019 (COVID-19) outbreak caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the wholesale market in …

The aim of this report is to review the literature and shed light on the uncertainties
surrounding the use of antiviral agents in general and remdesivir in COVID-19 patients. This …

Abstract The novel coronavirus 2019 (2019-nCoV), formally named severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a novel human infectious coronavirus. The …

The novel coronavirus strain, severe acute respiratory syndrome coronavirus-2, the
causative agent of COVID-19 emerged in Wuhan, China, in December 2019 and is …

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
etiology of COVID-19 pandemic, resulted in significant harm to the affected countries in …

Since December 2019, COVID-19 has spread across the world almost through 2.5 years. As
of 16 June 2022, the cumulative number of confirmed cases of COVID-19 worldwide has …

Since the emergence of coronavirus disease 2019 (Covid‐19), many studies have been
performed to characterize severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …